www.nice.org.uk/nicemedia/live/13671/58194/58194.pdf
Just considering deaths prevented: "£18,070,000 per QALY gained compared with an adrenaline auto-injector plus high-dose antihistamine and advice."
Taking into consideration quality of life: "The Committee noted that in these analyses the ICER for Pharmalgen decreased to less than £30,000 per QALY gained. "
Looking at the long term benefits over > 10 years: "with reduced anxiety about re-stings after treatment with Pharmalgen the most plausible ICER would be less than £20,000 per QALY gained."
Conclusion: "The Committee concluded that Pharmalgen is an appropriate use of NHS resources for people with IgE-mediated allergy to bee and wasp venom, who have a high risk of stings."
Thanks for that pbh4. A very interesting read indeed!
Could be perversely interpreted as justification for homeopathic desensitisation in those who are stung 3.1 times per annum or less